Last reviewed · How we verify
NCT05343026
Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss
NA trial testing Hearing aids in Tinnitus, Subjective in 62 participants. Status unknown.
1 July 2023
Quick facts
| Lead sponsor | Eye & ENT Hospital of Fudan University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 62 |
| Start date | 1 July 2022 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 December 2023 |
Drugs / interventions tested
- Hearing aids
Conditions studied
- Tinnitus, Subjective — all drugs for Tinnitus, Subjective →
- Hearing Loss, High-Frequency — all drugs for Hearing Loss, High-Frequency →
Sponsor
Eye & ENT Hospital of Fudan University
Who can join
Adults 18 to 70, any sex, with Tinnitus, Subjective or Hearing Loss, High-Frequency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the HA treatment group, and the other is the waiting list control (WLC) group which receives no interventions during this period.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of hearing aid treatment on sound perception and residual hearing preservation in patients with tinnitus and coexisting hearing loss: study protocol for a randomized controlled trial.
Li P, Tang D, Wu Y, Yin Y, et al · · 2022 · PMID 36575531 · DOI 10.1186/s13063-022-07014-0
Verify or expand the search:
- PubMed search for NCT05343026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hearing aids
Trials testing the same drug.
- NCT04823494 — Wear-Time Trial for Self-Fitting Hearing Aid · NA · completed
- NCT04663828 — UNification of Treatments and Interventions for TInnitus Patients - Randomized Clinical Trial (UNITI-RCT) · NA · completed
- NCT03973658 — Dizziness Among First Time Users of Hearing Aids · unknown
- NCT03002142 — Auditory Rehabilitation and Cognition in Alzheimer Patients · NA · completed
Other recruiting trials for Tinnitus, Subjective
Currently open trials in the same condition.
- NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
- NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
- NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting
- NCT06880367 — Neuromodulatory Effects of Audio-proprio-phonatory Reinforcement Training on Subjective Tinnitus, Demonstrated by High-d · NA · recruiting
- NCT06782308 — Tinnitus Patient Preferences Survey · recruiting
Other Eye & ENT Hospital of Fudan University trials
Trials by the same sponsor.
- NCT07522879 — A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re · Phase 2 · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
- NCT07320508 — Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · Phase 2 · recruiting
- NCT07315802 — New Pattern of Retinal Laser Treatment for PDR · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05343026 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eye & ENT Hospital of Fudan University
- Last refreshed: 25 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05343026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing